Using state administrative and pharmacy data bases to develop a clinical decision support tool for schizophrenia guidelines

Molly Finnerty, Richard Altmansberger, James Bopp, Sharon Carpinello, John P. Docherty, William Fisher, Peter Jensen, Parukutty Krishnan, Michael Mittleman, Mark Olfson, Joel Tricarico, Tom White, Chip Felton

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Administrative and pharmacy data bases represent a largely untapped resource for clinical decision support and quality improvement. In this study, we examined the feasibility of using New York State Office of Mental Health (NYSOMH) data bases to develop an automated clinical report to support implementation of schizophrenia guidelines. First we reviewed the structure of existing data bases for capacity and limitations in supporting guideline implementation. Second, we identified schizophrenia guideline recommendations and adherence measures that would be the focus of our implementation. Third, a preliminary report was programmed, based on operational definitions of the guideline recommendations. Finally, we developed user groups to define content and format of new reports, through an iterative process of field testing, feedback, and revision. Our experience suggests that administrative and pharmacy data bases, despite their limitations, can be used to develop guidelinebased clinical decision support tools for schizophrenia with high physician acceptability.

Original languageEnglish (US)
Pages (from-to)85-94
Number of pages10
JournalSchizophrenia Bulletin
Volume28
Issue number1
StatePublished - 2002
Externally publishedYes

Fingerprint

Clinical Decision Support Systems
Schizophrenia
Databases
Guidelines
Guideline Adherence
Quality Improvement
Mental Health
Physicians

Keywords

  • Antipsychotic agents
  • Clinical decision support
  • Evidence-based medicine
  • Guideline adherence
  • Guideline implementation
  • Quality indicators
  • Schizophrenia

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Neuroscience(all)

Cite this

Finnerty, M., Altmansberger, R., Bopp, J., Carpinello, S., Docherty, J. P., Fisher, W., ... Felton, C. (2002). Using state administrative and pharmacy data bases to develop a clinical decision support tool for schizophrenia guidelines. Schizophrenia Bulletin, 28(1), 85-94.

Using state administrative and pharmacy data bases to develop a clinical decision support tool for schizophrenia guidelines. / Finnerty, Molly; Altmansberger, Richard; Bopp, James; Carpinello, Sharon; Docherty, John P.; Fisher, William; Jensen, Peter; Krishnan, Parukutty; Mittleman, Michael; Olfson, Mark; Tricarico, Joel; White, Tom; Felton, Chip.

In: Schizophrenia Bulletin, Vol. 28, No. 1, 2002, p. 85-94.

Research output: Contribution to journalArticle

Finnerty, M, Altmansberger, R, Bopp, J, Carpinello, S, Docherty, JP, Fisher, W, Jensen, P, Krishnan, P, Mittleman, M, Olfson, M, Tricarico, J, White, T & Felton, C 2002, 'Using state administrative and pharmacy data bases to develop a clinical decision support tool for schizophrenia guidelines', Schizophrenia Bulletin, vol. 28, no. 1, pp. 85-94.
Finnerty M, Altmansberger R, Bopp J, Carpinello S, Docherty JP, Fisher W et al. Using state administrative and pharmacy data bases to develop a clinical decision support tool for schizophrenia guidelines. Schizophrenia Bulletin. 2002;28(1):85-94.
Finnerty, Molly ; Altmansberger, Richard ; Bopp, James ; Carpinello, Sharon ; Docherty, John P. ; Fisher, William ; Jensen, Peter ; Krishnan, Parukutty ; Mittleman, Michael ; Olfson, Mark ; Tricarico, Joel ; White, Tom ; Felton, Chip. / Using state administrative and pharmacy data bases to develop a clinical decision support tool for schizophrenia guidelines. In: Schizophrenia Bulletin. 2002 ; Vol. 28, No. 1. pp. 85-94.
@article{ff1e1e3ac1084a81ba4fffbec4137d99,
title = "Using state administrative and pharmacy data bases to develop a clinical decision support tool for schizophrenia guidelines",
abstract = "Administrative and pharmacy data bases represent a largely untapped resource for clinical decision support and quality improvement. In this study, we examined the feasibility of using New York State Office of Mental Health (NYSOMH) data bases to develop an automated clinical report to support implementation of schizophrenia guidelines. First we reviewed the structure of existing data bases for capacity and limitations in supporting guideline implementation. Second, we identified schizophrenia guideline recommendations and adherence measures that would be the focus of our implementation. Third, a preliminary report was programmed, based on operational definitions of the guideline recommendations. Finally, we developed user groups to define content and format of new reports, through an iterative process of field testing, feedback, and revision. Our experience suggests that administrative and pharmacy data bases, despite their limitations, can be used to develop guidelinebased clinical decision support tools for schizophrenia with high physician acceptability.",
keywords = "Antipsychotic agents, Clinical decision support, Evidence-based medicine, Guideline adherence, Guideline implementation, Quality indicators, Schizophrenia",
author = "Molly Finnerty and Richard Altmansberger and James Bopp and Sharon Carpinello and Docherty, {John P.} and William Fisher and Peter Jensen and Parukutty Krishnan and Michael Mittleman and Mark Olfson and Joel Tricarico and Tom White and Chip Felton",
year = "2002",
language = "English (US)",
volume = "28",
pages = "85--94",
journal = "Schizophrenia Bulletin",
issn = "0586-7614",
publisher = "Oxford University Press",
number = "1",

}

TY - JOUR

T1 - Using state administrative and pharmacy data bases to develop a clinical decision support tool for schizophrenia guidelines

AU - Finnerty, Molly

AU - Altmansberger, Richard

AU - Bopp, James

AU - Carpinello, Sharon

AU - Docherty, John P.

AU - Fisher, William

AU - Jensen, Peter

AU - Krishnan, Parukutty

AU - Mittleman, Michael

AU - Olfson, Mark

AU - Tricarico, Joel

AU - White, Tom

AU - Felton, Chip

PY - 2002

Y1 - 2002

N2 - Administrative and pharmacy data bases represent a largely untapped resource for clinical decision support and quality improvement. In this study, we examined the feasibility of using New York State Office of Mental Health (NYSOMH) data bases to develop an automated clinical report to support implementation of schizophrenia guidelines. First we reviewed the structure of existing data bases for capacity and limitations in supporting guideline implementation. Second, we identified schizophrenia guideline recommendations and adherence measures that would be the focus of our implementation. Third, a preliminary report was programmed, based on operational definitions of the guideline recommendations. Finally, we developed user groups to define content and format of new reports, through an iterative process of field testing, feedback, and revision. Our experience suggests that administrative and pharmacy data bases, despite their limitations, can be used to develop guidelinebased clinical decision support tools for schizophrenia with high physician acceptability.

AB - Administrative and pharmacy data bases represent a largely untapped resource for clinical decision support and quality improvement. In this study, we examined the feasibility of using New York State Office of Mental Health (NYSOMH) data bases to develop an automated clinical report to support implementation of schizophrenia guidelines. First we reviewed the structure of existing data bases for capacity and limitations in supporting guideline implementation. Second, we identified schizophrenia guideline recommendations and adherence measures that would be the focus of our implementation. Third, a preliminary report was programmed, based on operational definitions of the guideline recommendations. Finally, we developed user groups to define content and format of new reports, through an iterative process of field testing, feedback, and revision. Our experience suggests that administrative and pharmacy data bases, despite their limitations, can be used to develop guidelinebased clinical decision support tools for schizophrenia with high physician acceptability.

KW - Antipsychotic agents

KW - Clinical decision support

KW - Evidence-based medicine

KW - Guideline adherence

KW - Guideline implementation

KW - Quality indicators

KW - Schizophrenia

UR - http://www.scopus.com/inward/record.url?scp=0035988526&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035988526&partnerID=8YFLogxK

M3 - Article

VL - 28

SP - 85

EP - 94

JO - Schizophrenia Bulletin

JF - Schizophrenia Bulletin

SN - 0586-7614

IS - 1

ER -